| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/06/2003 | US20030027832 4-Phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 02/06/2003 | US20030027823 N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 02/06/2003 | US20030027812 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
| 02/06/2003 | US20030027797 For therapy of metabolic disorders related to insulin resistance or hyperglycemia |
| 02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
| 02/06/2003 | US20030026763 Using water soluble dyes |
| 02/06/2003 | US20030026521 Optical interleaver |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2453106A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules |
| 02/05/2003 | EP1282084A2 Method for preparing pyrimidone derivatives with antifungal activity |
| 02/05/2003 | EP1281709A1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/05/2003 | EP1280797A1 Inhibitors of dipeptidyl peptidase iv |
| 02/05/2003 | EP1280796A1 Pyrimidinyl methyl indole derivatives with antibacterial activity |
| 02/05/2003 | EP1280795A2 N-substituted carbamoyloxyalkyl-azolium derivatives |
| 02/05/2003 | EP1280793A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 02/05/2003 | EP1280781A1 5-ht 7 receptor antagonists |
| 02/05/2003 | EP0984960B1 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists |
| 02/05/2003 | EP0848706B1 Substituted benzene-fused heterocyclics as neurokinin antagonists |
| 02/05/2003 | EP0817632B1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 02/05/2003 | CN1395568A 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/05/2003 | CN1395563A Isatine derivatives with neurotrophic activity |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1395485A Water soluble prodrugs of azole compounds |
| 02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
| 02/05/2003 | CN1100761C Benzyloxy substituted aryl copounds and their use as fungicides and insecticides |
| 02/05/2003 | CN1100540C Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
| 02/04/2003 | US6515133 Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6515013 For diseases or conditions caused by or exacerbated by histamine-3 receptor activity |
| 02/04/2003 | US6515011 Anticoagulants |
| 02/04/2003 | US6515003 Useful in the treatment of diseases related to lipid and carbohydrate metabolism |
| 02/04/2003 | US6514998 For controlling animal pests and harmful fungi |
| 02/04/2003 | US6514993 Serotonin 5-HT1A and dopamin D2 receptor ligands |
| 02/04/2003 | US6514990 Pharmaceutically active compounds and methods of use |
| 02/04/2003 | US6514981 Methods of modulating tyrosine protein kinase function with indolinone compounds |
| 02/04/2003 | US6514977 For treating p38 kinase mediated disorders |
| 02/04/2003 | US6514975 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 02/04/2003 | US6514974 Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity |
| 02/04/2003 | US6514971 Cinnoline derivatives and use as medicine |
| 02/04/2003 | US6514970 Urotensin-II receptor antagonists |
| 02/04/2003 | US6514968 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising |
| 02/04/2003 | US6514964 Treating diseases, conditions or disorders mediated by integrin receptors, such as vitronectin and fibronectin receptors |
| 02/04/2003 | CA2271566C Substituted phenyl pyrimidines useful in the treatment of cns disorders |
| 01/31/2003 | CA2396020A1 Imidazolidinone derivatives |
| 01/30/2003 | WO2003008410A2 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 01/30/2003 | WO2003008409A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/30/2003 | WO2003008407A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 01/30/2003 | WO2003008405A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres |
| 01/30/2003 | WO2003008387A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 01/30/2003 | WO2003008377A1 Prostaglandin analogues_as ep4 receptor agonists |
| 01/30/2003 | WO2003007959A1 Quinoxaline derivatives which have parp inhibitory action |
| 01/30/2003 | WO2003007958A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 01/30/2003 | WO2003007945A1 Viral polymerase inhibitors |
| 01/30/2003 | WO2003007883A2 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 01/30/2003 | WO2002088079A3 Dual inhibitors of pde 7 and pde 4 |
| 01/30/2003 | US20030023098 Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors |
| 01/30/2003 | US20030023087 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 01/30/2003 | US20030023031 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 01/30/2003 | US20030022927 Novel benzimidazole derivatives |
| 01/30/2003 | US20030022907 Anxiolytic agents and analgesics |
| 01/30/2003 | US20030022905 Prevention and/or therapy of ischaemia and reperfusion damage; poly(ADP-ribose)-synthetase inhibitors |
| 01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
| 01/30/2003 | US20030022884 Heterocycle derivatives and drugs |
| 01/30/2003 | US20030022794 Bioactive pesticides |
| 01/30/2003 | US20030019050 Novel cationic 4-hydroxyindoles, their use for the oxidation dyeing of keratinous fibers, dyeing compositions, and methods of dyeing |
| 01/30/2003 | CA2454187A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 01/30/2003 | CA2454007A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 01/30/2003 | CA2453636A1 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 01/30/2003 | CA2453594A1 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| 01/30/2003 | CA2451392A1 Prostaglandin analogues as ep4 receptor agonists |
| 01/30/2003 | CA2450437A1 1-phenylsulphonyl-1,3-dihydro-2h-indol-2-one derivatives, their preparation and their therapeutic application |
| 01/29/2003 | EP1279673A1 Imidotriazine derivatives |
| 01/29/2003 | EP1279666A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
| 01/29/2003 | EP1278748A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/29/2003 | EP1278743A1 Novel anti-infectives |
| 01/29/2003 | EP1278740A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 01/29/2003 | EP1278735A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 01/29/2003 | EP1278728A1 Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 01/29/2003 | EP1028948B1 Phenyl-alkyl-imidazoles as h3 receptor antagonists |
| 01/29/2003 | CN1394205A Indazole compounds, pharmaceutical compositions, and their use for mediating or inhibiting cell proliferation |
| 01/29/2003 | CN1393444A Compound for treating impotence |
| 01/29/2003 | CN1100055C Piperazine and piperidine compounds |
| 01/29/2003 | CN1100046C 喹唑啉衍生物 Quinazoline derivatives |
| 01/28/2003 | WO2002010155A1 Substituted aryl ketones and their use as herbicides |
| 01/28/2003 | US6512001 D-proline derivatives |
| 01/28/2003 | US6512000 Aminocarbonyl-substituted benzimidazoles having tryptase-inhibitory activity |
| 01/28/2003 | US6511998 Pyrazole carboxamides useful for the treatment of obesity and other disorders |
| 01/28/2003 | US6511978 Pyrrole derivatives useful for farnesyl transferase inhibitors and their preparations |
| 01/28/2003 | US6511941 Synergistic mixture |
| 01/28/2003 | US6511663 Tri- and tetra-valent monospecific antigen-binding proteins |
| 01/28/2003 | CA2417385A1 Substituted aryl ketones and their use as herbicides |
| 01/28/2003 | CA2083534C Indolopyrrolocarbazole derivatives |
| 01/24/2003 | CA2394209A1 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands |
| 01/23/2003 | WO2003006506A2 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/23/2003 | WO2003006459A1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity |
| 01/23/2003 | WO2003006447A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/23/2003 | WO2003006443A2 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy |
| 01/23/2003 | WO2003006437A1 Imidazole derivatives as adenosine deaminase inhibitors |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006012A1 Compounds and methods for the inhibition of trypanosoma cruz i |